Jessie Owen was severely injured and paralyzed below the shoulders in 2012 when a tree fell on her family’s vehicle as they ...

The global spinal devices market is set to witness remarkable expansion, projected to grow at a CAGR of 5.3% during the period 2022-2032. According to comprehensive market research, the industry is ...

A new FDA-approved device is bringing hope to people who have suffered spinal injuries and helping them regain function they ...

Everyone has probably dealt with at least a little physical pain in their life.But fortunately, the number of peop ...

“We believe that the spinal implants business, with its comprehensive portfolio and strong sales channel, will thrive as an ...

Therapeutic breakthroughs in neuromodulation merge wearable technologies, deep brain implants, and tailored stimulations ...

UW Medicine is unveiling an FDA-approved spinal cord therapy in an effort to offer new hope for paralyzed patients.

Spinal cord stimulation can be an effective treatment for managing pain associated with diabetic peripheral neuropathy, especially if other therapies have been ineffective. Following a trial period, ...

Recently, Dr. J. Alex Sielatycki, a fellowship-trained spine surgeon at Pioneers Medical Center (PMC) in Meeker, started ...

Stryker reported goodwill and other impairments of $818 million related to the spine business in the fourth quarter.

Spine Chronicle Japan, which develops spinal treatment devices using proprietary technology, announced on the 10th that it has raised 135 million yen in a Series A round led by Diamond Medino Capital.